You don’t know that. Innocent until proven guilty. The law of the land.
No matter how flat you make a pancake, it still has two sides. I don’t think the investigators understand what a blood panel is, as opposed to a single blood test. That is an important point. There are other allegations that don’t make that much sense. If this goes to trial, the SEC will have to prove each and every count and that won’t be easy. Do the exaggerations come under the category of “puffery,” which is not illegal? Are “kickbacks” and “bribery” truly what was going on? Or was it incentive pay and commissions that they’re talking about? Notice how they talk about the share price being very low due to dilution, insinuating the company was dumping shares into the market for personal gain, when everyone who has been following the company knows why that dilution had to happen. I have many questions after re-reading everything.
Just sayin’. I know it’s not pretty so please don’t reply with the usual negative comments that are already OBVIOUS.
Interesting that the complaint is against Mark individually and not Arrayit Corporation. They are still operating the business. Mark was at work when he was suddenly interviewed a few days ago. He said they were still working with the FDA.
I don’t think ARYC was always a scam. They have been in business for 26 years. They probably should not have gone public and/or gotten involved with Taub, which was when most of the trouble started. I believe they were primarily trying to get OvaDx approved and commercialized, as well as the food safety test, and things spiraled out of control due to poor decisions and crooked lenders and the high cost of R&D.
